Catalogue Number
BN-O1035
Analysis Method
Specification
98%(HPLC)
Storage
-20℃
Molecular Weight
409.43
Appearance
Powder
Botanical Source
Structure Type
Category
SMILES
C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O
Synonyms
Ezetimide/Zetia/EzitiMibeEzetiMibeC24H21F2N03/Ezetrol/(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one/Int/(3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone/ezetimibe/EzetiMib/(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one/(3R,4S)-1-(4-Fluorphenyl)-3-[(3S)-3-(4-fluorphenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-on/2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, (3R,4S)-
IUPAC Name
Density
1.3±0.1 g/cm3
Solubility
Flash Point
349.9±31.5 °C
Boiling Point
654.9±55.0 °C at 760 mmHg
Melting Point
164-166a„ƒ
InChl
InChI=1S/C16H14O4/c1-18-10-3-5-11-13-8-19-14-6-9(17)2-4-12(14)16(13)20-15(11)7-10/h2-7,13,16-17H,8H2,1H3/t13-,16-/m1/s1
InChl Key
OLNTVTPDXPETLC-XPWALMASSA-N
WGK Germany
RID/ADR
HS Code Reference
Personal Projective Equipment
Correct Usage
For Reference Standard and R&D, Not for Human Use Directly.
Meta Tag
provides coniferyl ferulate(CAS#:163222-33-1) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate
No Technical Documents Available For This Product.
28231943
acute coronary syndrome; ezetimibe; low-density lipoprotein cholesterol; risk stratification; secondary prevention; statin.
Who Should Receive Ezetimibe?
Gregory G Schwartz 1
2017 Feb 28
26324293
Patients who take statins frequently experience adverse events, typically muscle symptoms. Some of these patients develop statin intolerance and discontinue the statin treatment. The treatment of a statin intolerant patient can be difficult. Treatment possibilities include a low dose regimen of statin, possibly in combination with another lipid-lowering agent, most commonly ezetimibe.
[Statin Intolerance]
Christina Boesgaard Graversen 1, Mogens Lytken Larsen, Erik Berg Schmidt
2015 Aug 31
25659868
New Insights on Ezetimibe. Introduction
Alberico L Catapano 1
2015 Feb;
Description :
Empty ...